Multivariate survival analysis of patients with stage III–IV colon cancer: clinical and biological factors and the impact of treatment regimen
Improved survival was observed in patients receiving combined inhibition of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) compared with VEGF inhibitor-based therapy alone and among patients with stage IV disease, survival was also associated with the type of targeted therapy admi...